Dr. Andra Leah Blomkalns, MD

Dr. Blomkalns practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Blomkalns' NPI, 1275634529, was assigned on September 26, 2006. Dr. Blomkalns graduated from LSU Health Shreveport School of Medicine in 1997. Dr. Blomkalns holds California license C156810.

Dr. Blomkalns' primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Blomkalns' primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Blomkalns to 1 more hospital and 2 medical groups, each named with a free account. Dr. Blomkalns' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blomkalns practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Blomkalns' primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Blomkalns is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Blomkalns' licenses on file in 4 states: California, Ohio, Texas and Florida.

CMS data shows 133 Medicare services from Dr. Blomkalns across 3 procedure codes in 2024, for 140 Medicare patients. Medicare paid $18,840 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 140 Medicare patients who saw Dr. Blomkalns in 2024. The largest group is 75 to 84, with 55 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blomkalns' median patient age at 52, with 53% women.

In 2024, Dr. Blomkalns wrote 25 Medicare Part D claims for 16 patients. 96% of them were for generic drugs. They cover 3 drugs, with $353 in total drug cost. In 2016, CMS named 35 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Blomkalns for performance year 2024, reported as part of a group. Dr. Blomkalns accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 70 papers to Dr. Blomkalns, published from 2007 to 2025. 2021 was the busiest year, with 6. The most frequent topics are Emergency Service, Hospital, Emergency Medicine and COVID-19. Dr. Blomkalns has published most often in Acad Emerg Med. Dr. Blomkalns' most frequent co-authors are Catherine Anne Blish, MD, Deborah Baker Diercks, MD and Angela Jean Rogers, MD.

Dmand AI links Dr. Blomkalns to 1 clinical trial. Conditions studied include COVID-19 and Pneumonia, Viral. Open Payments lists research payments to Dr. Blomkalns that name 1 trial.

CMS Open Payments shows 1 general payment to Dr. Blomkalns from 1 drug or device company in 2016. Gifts make up the largest share, 100% of the total. NeuroMetrix Inc paid the most, $126. It also lists 1 research payment totaling $71,106 in 2020, naming 1 clinical trial.

Dr. Blomkalns graduated from LSU Health Shreveport School of Medicine in 1997.

Dr. Blomkalns is in network with 14 carriers, including United Healthcare, Aetna and Alliant Health Plans. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.